Viela Bio, Inc.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $11.7M
- Net Income/Loss (FY2020)
- -$150.7M
- Total Assets (FY2020)
- $423.3M
- Total Equity (FY2020)
- $375.8M
- Cash Flows from Operating Activities (FY2020)
- -$106.1M
Source: Viela Bio, Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
